En español

NIDA Notes Articles: Medication Development

NIDA Notes Category Graphic

Quinine as a Tracer for Medication Adherence

September 2016

Patients who don’t take their medications as prescribed often put themselves at risk for problems including misdiagnoses, complications, and death. A study suggests that adding low doses of quinine to patients’ medications could provide an expensive, reliable, and safe method of monitoring whether patients are taking their medications as directed.

NIDA Notes Category Graphic

Dual Regimen Aims To Shorten Medication-Assisted Therapy

May 2016

Treatment that combines use of Bp/Nx and memantine may enable young adults addicted to opioids establish lasting abstinence after a relatively brief course of medication-assisted therapy, a pilot trial suggests.

NIDA Notes Category Graphic

Narrative of Discovery: In Search of a Medication To Treat Methamphetamine Addiction, Part 2

April 2016

When lobeline turned out not to be the answer, it became a starting point. Dr. Linda Dwoskin and her team set out to transform the molecule into something more effective and with fewer side effects.

NIDA Notes Category Graphic

Testing a Prospective Medication To Help People Avoid Relapse

March 2016

This NIDA Notes animation depicts a basic experiment that researchers use to test whether a prospective new medication can prevent relapse to drug addiction.

NIDA Notes Category Graphic

Dr. Thomas Kosten Q & A: Vaccines To Treat Addiction

June 2015

In this article and accompanying podcast, Dr. Thomas Kosten discusses the idea and current status of antidrug vaccines to treat substance use and addiction.

NIDA Notes Category Graphic

Narrative of Discovery: In Search of a Medication To Treat Methamphetamine Addiction

January 2015

This is the first in a series of NIDA Notes articles that will follow a team of researchers seeking a medication for methamphetamine addiction. This installment describes the early promise of the compound lobeline and the new directions the team discovered in studying it.

NIDA Notes Category Graphic

Dr. Kevin M. Gray Q & A: A Potential Medication for Marijuana Dependence

October 2014

Dr. Kevin M. Gray discusses why it’s the perfect time for discovering new evidence-based treatments for marijuana dependence. In an accompanying podcast, he discusses a clinical trial that examines NAC’s potential as a treatment for marijuana dependence among adults.

NIDA Notes Category Graphic

Microneedle Milestone: One Week of Transdermal Drug Delivery

March 2014

Microneedles are an innovative technique for delivering medications through the skin, a route that could particularly benefit patients receiving naltrexone therapy for opioid and alcohol dependence. Researchers have found a way to use the transdermal technique to deliver a single treatment of naltrexone that lasts for 7 days.

NIDA Notes Category Graphic

Stress-Induced Enzyme Compounds Methamphetamine Neurotoxicity

January 2014

Ketoprofen, an anti-inflammatory agent commonly prescribed to treat arthritis, reduces neuronal damage in rats that have been exposed to chronic stress and methamphetamine. If this finding of a recent NIDA-supported study extrapolates to humans, anti-inflammatory medications may gain a place in the treatment of methamphetamine addiction.

NIDA Notes Category Graphic

Naltrexone Implant Outperforms Daily Pill in Russian Trial

November 2013

More than half of heroin-addicted patients treated with naltrexone via an implanted delivery device maintained abstinence throughout a 6-month clinical trial in Saint Petersburg, Russia. The implant device, which releases a steady dose of naltrexone continuously for 2 months, averted relapse to heroin use three times as effectively as daily oral doses of the medication.


NIDA Notes


Drug Topics

Drugs of Abuse

Population Groups

Related Topics